Drugs with a negative impact on cognitive functions (Part 2): drug classes to consider while prescribing in CKD patients

There is growing evidence that chronic kidney disease (CKD) is an independent risk factor for cognitive impairment, especially due to vascular damage, blood–brain barrier disruption and uremic toxins. Given the presence of multiple comorbidities, the medication regimen of CKD patients often becomes...

Descripción completa

Detalles Bibliográficos
Autores principales: Hafez, Gaye, Malyszko, Jolanta, Golenia, Aleksandra, Klimkowicz-Mrowiec, Aleksandra, Ferreira, Ana Carina, Arıcı, Mustafa, Bruchfeld, Annette, Nitsch, Dorothea, Massy, Ziad A, Pépin, Marion, Capasso, Giovambattista, Mani, Laila-Yasmin, Liabeuf, Sophie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
CKJ Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689198/
https://www.ncbi.nlm.nih.gov/pubmed/38046029
http://dx.doi.org/10.1093/ckj/sfad239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689198/
https://www.ncbi.nlm.nih.gov/pubmed/38046029
http://dx.doi.org/10.1093/ckj/sfad239

Ejemplares similares